- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Geriatrics
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Oncology
- Nephrology
- Neurology
- Pulmonology
Pearls for Solving Problems when Treating Psoriasis: From the Experts
Dermatology experts share pearls to help when biologics alone are not enough, when obesity is a comorbidity with psoriasis, and when isotype switching derails therapy.
Wisdom and therapeutic advice in psoriasis was a team presentation by April W. Armstrong, MD, MPH, Mark Lebwohl, MD, Joseph F. Merola, MD, MMSc, and Ron Vender, MD that focused on strategies to aid treatment when biologics alone are not enough to achieve desired outcomes for patients psoriasis, when obesity is a comorbidity impeding treatment of psoriasis, and when isotype switching derails therapy, creating entirely new problems to deal with. The session was part of the 2025 Midwinter Clinical Hawaii Dermatology Conference, held February 15-29, 2025, on the Big Island, Waikoloa Village, HI.
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.
